These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3234702)

  • 1. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
    Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.
    Clark GM; Dressler LG; Owens MA; Pounds G; Oldaker T; McGuire WL
    N Engl J Med; 1989 Mar; 320(10):627-33. PubMed ID: 2918874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
    Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
    J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
    Kaufmann M; Klinga K; Kühn W; Abel U
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
    Velanovich V
    Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
    Hedley DW; Rugg CA; Ng AB; Taylor IW
    Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicators of prognosis in node-negative breast cancer.
    Sigurdsson H; Baldetorp B; Borg A; Dalberg M; Fernö M; Killander D; Olsson H
    N Engl J Med; 1990 Apr; 322(15):1045-53. PubMed ID: 2320064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
    Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
    Hedley DW; Rugg CA; Gelber RD
    Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
    Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.